Načítá se...

Neuroimaging Biomarkers for Clinical Trials of Disease-Modifying Therapies in Alzheimer's Disease

Summary: The pathophysiologic process leading to neurodegeneration in Alzheimer's disease (AD) is thought to begin long before clinical symptoms develop. Existing therapeutics for AD improve symptoms, but increasing efforts are being directed toward the development of therapies to impede the pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dickerson, Bradford C., Sperling, Reisa A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Am. Soc. for Experimental NeuroTherapeutics 2005
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064996/
https://ncbi.nlm.nih.gov/pubmed/15897955
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!